BRIEF published on 10/28/2026 at 06:35, 4 days 15 hours ago Sensorion participates in the 33rd ESGCT Congress Gene Therapy Deafness SENS-601 Sensory ESGCT 2026
BRIEF published on 10/28/2026 at 06:35, 4 days 15 hours ago Sensorion participe au 33e Congrès de l'ESGCT Thérapie Génique Sensorion Surdité SENS-601 ESGCT 2026
PRESS RELEASE published on 10/28/2026 at 06:30, 4 days 15 hours ago Informations privilégiées / Autres communiqués
BRIEF published on 10/19/2026 at 10:33, 13 days 11 hours ago Sensorion appoints Peter Weber as Chief Medical Officer Appointment Gene Therapy Hearing Loss Sensory Peter Weber
BRIEF published on 10/19/2026 at 10:33, 13 days 11 hours ago Sensorion nomme Peter Weber au poste de Directeur Médical Nomination Thérapie Génique Sensorion Perte Auditive Peter Weber
PRESS RELEASE published on 10/19/2026 at 10:28, 13 days 11 hours ago Informations privilégiées / Autres communiqués Nomination de Peter Weber, MD, MBA, en tant que Directeur Médical chez Sensorion. Expert en thérapie génique pour surdités génétiques Thérapie Génique Sensorion Directeur Médical Peter Weber Surdité Génétique
BRIEF published on 10/07/2026 at 07:35, 25 days 14 hours ago Louis J. Arcudi III nommé Directeur Financier de Sensorion Nomination Directeur Financier Sensorion SENS-601 Louis J. Arcudi III
BRIEF published on 10/07/2026 at 07:35, 25 days 14 hours ago Louis J. Arcudi III appointed Chief Financial Officer of Sensorion Chief Financial Officer Appointment SENS-601 Sensory Louis J. Arcudi III
PRESS RELEASE published on 10/07/2026 at 07:30, 25 days 14 hours ago Inside Information / Other news releases Sensorion appoints Louis J. Arcudi III as Chief Financial Officer. Arcudi brings extensive biopharmaceutical industry experience to the role Chief Financial Officer Biopharmaceutical Industry Financial Leadership Sensorion Louis J. Arcudi III
PRESS RELEASE published on 10/07/2026 at 07:30, 25 days 14 hours ago Informations privilégiées / Autres communiqués Sensorion annonce la nomination de Louis J. Arcudi III en tant que Directeur Financier, apportant une riche expérience en biopharmaceutique. Il succède à Laurene Danon et travaillera sous la direction de Fred Chereau Biopharmaceutique Directeur Financier Sensorion Fred Chereau Louis J. Arcudi III
Published on 10/30/2026 at 23:35, 1 day 22 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 22 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 3 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 6 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 11 hours 25 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 17 hours ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 5 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 23 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 23 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 1 day 23 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
